Literature DB >> 9018990

Pneumatic retinopexy: principles and practice.

G F Hilton1, T Das, A B Majji, S Jalali.   

Abstract

Pneumatic retinopexy (PR) is an alternative to scleral buckling for the surgical repair of selected retinal detachments. A gas bubble is injected into the vitreous cavity, and the patient is positioned so that the bubble closes the retinal break (s), allowing absorption of the subretinal fluid. Cryotherapy or laser photocoagulation is applied around the retinal break(s) to form a permanent seal. The procedure can be done in an outpatient setting, and no incisions are required. A multicenter randomized controlled clinical trial has demonstrated that the anatomic success rate is comparable to scleral buckling, but the morbidity is significantly less with PR. If the macula was detached for less than two weeks, the visual results are significantly better with PR than with scleral buckling. Cataract surgery was required significantly more often following scleral buckling than following PR. Two independent reports have shown that an attempt with PR does not disadvantage the eye; such that the results of scleral buckling after failed PR are not significantly different than primary scleral buckling. A comprehensive review of the world literature on PR revealed 27 statistical series totaling 1,274 eyes. These combined series had a single-operation success rate of 80%, and 98% were cured with reoperations. Pneumatic retinopexy should be considered in cases without inferior or extensive retinal breaks and without significant proliferative vitreoretinopathy. The cost of buckling varies from 4 to 10 times that of PR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018990

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  12 in total

1.  Secondary pneumatic retinopexy for failed scleral buckle.

Authors:  Divya Balakrishnan; Avadhesh Oli
Journal:  BMJ Case Rep       Date:  2019-08-10

2.  Anatomic, Visual, and Financial Outcomes for Traditional and Nontraditional Primary Pneumatic Retinopexy for Retinal Detachment.

Authors:  Jesse J Jung; John Cheng; Jane Y Pan; Daniel A Brinton; Quan V Hoang
Journal:  Am J Ophthalmol       Date:  2019-01-24       Impact factor: 5.258

3.  PNEUMATIC RETINOPEXY IN RHEGMATOGENOUS RETINAL DETACHMENT.

Authors:  R P Gupta; M Deshpande; A Bharadwaj; V K Baranwal
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Long term results of pneumatic retinopexy.

Authors:  Amin F Ellakwa
Journal:  Clin Ophthalmol       Date:  2012-01-09

5.  Outcomes of Pneumatic Retinopexy for the Management of Rhegmatogenous Retinal Detachment at a Tertiary Care Center.

Authors:  Mohammad A Hazzazi; Saba Al Rashaed
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep

6.  Pneumatic retinopexy combined with scleral buckling in the management of relatively complicated cases of rhegmatogenous retinal detachment: A multicenter, retrospective, observational consecutive case series.

Authors:  Chuandi Zhou; Qiurong Lin; Yuxin Wang; Qinghua Qiu
Journal:  J Int Med Res       Date:  2017-08-25       Impact factor: 1.671

7.  Assessment of Postural Compliance After Pneumatic Retinopexy.

Authors:  Raul Velez-Montoya; Ana González-H León; Everardo Hernández-Quintela
Journal:  Transl Vis Sci Technol       Date:  2019-05-02       Impact factor: 3.283

8.  Endothelial corneal cell damage after pars plana vitrectomy: analogy of different intraocular tamponade agents.

Authors:  Corina Cristina Coman Cernat; Stella Ioana Patoni Popescu; Daniel Malița; Simona Stanca; Ovidiu Mușat; Șerban Negru; Horea Feier; Olimpiu Ladislau Karancsi; Cosmin Roșca
Journal:  Rom J Ophthalmol       Date:  2021 Apr-Jun

9.  Reassessment of pneumatic retinopexy for primary treatment of rhegmatogenous retinal detachment.

Authors:  Eyal Cohen; Amir Zerach; Michael Mimouni; Adiel Barak
Journal:  Clin Ophthalmol       Date:  2015-11-02

Review 10.  Pneumatic retinopexy: patient selection and specific factors.

Authors:  Stephen Stewart; Wing Chan
Journal:  Clin Ophthalmol       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.